✦ LIBER ✦

Is NIH funding predictive of greater research productivity and impact among academic otolaryngologists?

✍ Scribed by Peter F. Svider; Kevin M. Mauro; Saurin Sanghvi; Michael Setzen; Soly Baredes; Jean Anderson Eloy

Book ID: 118763720
Publisher: John Wiley and Sons
Year: 2012
Tongue: English
Weight: 327 KB
Volume: 123
Category: Article
ISSN: 0023-852X
DOI: 10.1002/lary.23659

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Is the h-index Predictive of Greater NIH

Is the h-index Predictive of Greater NIH Funding Success Among Academic Radiologists?

✍ Rezek, Issa; McDonald, Robert J.; Kallmes, David F. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 102 KB

Is There a Relationship between National

Is There a Relationship between National Institutes of Health Funding and Research Impact on Academic Urology?

✍ Colaco, Marc; Svider, Peter F.; Mauro, Kevin M.; Eloy, Jean Anderson; Jackson-Ro 📂 Article 📅 2013 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 675 KB

Cooperative Research Centers and Technic

Cooperative Research Centers and Technical Innovation Volume 6936 || Is Cooperative Research Center Affiliation Amongst Academic Researchers Stratifying the Academy? The Impacts of Departmental Prestige, Career Trajectory, and Productivity on Center Affiliation

✍ Boardman, Craig; Gray, Denis O.; Rivers, Drew 📂 Article 📅 2012 🏛 Springer New York ⚖ 266 KB

Can multiparametric magnetic resonance i

Can multiparametric magnetic resonance imaging predict upgrading of transrectal ultrasound biopsy results at more definitive histology?11Mohamed Abd-Alazeez receives funding from the Egyptian government. Mark Emberton and Hashim U. Ahmed receive funding from USHIFU and Advanced Medical Diagnostics for clinical trials. Mark Emberton is a paid consultant for Steba Biotech, USHIFU and Sanofi-Aventis. Mark Emberton has received research support by GSK for a study evaluating the role of MRI in men with prostate cancer. Mark Emberton and Hashim Ahmed have previously received medical consultancy fees from GE Healthcare/Oncura and Hashim Ahmed previously from Steba Biotech. Mark Emberton is a medical director of Mediwatch PLC. Hashim Uddin Ahmed and Mark Emberton receive funding from the Medical Research Council, the NIHR-HTA, NIHR-i4i, the US NIH/NCI, Pelican Cancer Foundation, Prostate Cancer UK, and St Peter׳s Trust. This work was part funded by research support for Mark Emberton and Alex Kirkham from the UK National Institute of Health Research UCLH/UCL Comprehensive Biomedical Research Centre, London, UK.

✍ Abd-Alazeez, Mohamed; Ahmed, Hashim U.; Arya, Manit; Allen, Clare; Dikaios, Niko 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 415 KB